ஹோவர்ட் மிதவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Background: The recent trend of pharmaceutical companies commercializing new objects as new drugs based on the findings of academic medical researchers, commonly categorizing them as “academic drug discovery” is increasingly gaining popularity in the pharmaceutical industry. Studies state that academic researchers based in universities have lower motivation to apply for patents. However, none of the studies evaluated the existence and extent of the “motivation for patent” in academic researchers, being lower than that of pharmaceutical companies. This study assesses two hypotheses; H1: academic medical researchers are less likely to believe that the patent system is necessary for pharmaceuticals, and thus have diminished interest in the commercialization of their research findings when compared to those in the pharmaceutical industry, H2: apprehension of the raison d’être of the patent system affects positive impressions on patents among academic medical researchers.

United statesHoward floreyAlexander flemingJikei university school of medicineKyoto universityProperty association of japanSapporo medical universitySapporo medical university in hokkaidoKanazawa institute of technologyJapan pharmaceutical manufacturers associationOsaka institute of technologyJapan agency for medical researchMeiji universityTokyo university of scienceCore research facilitiesPatent law